What does the evidence show about Red light therapy / photobiomodulation (PBM)'s effects?

Read Off Label rates the evidence for Red light therapy / photobiomodulation (PBM) as Moderate and the benefit magnitude as med, producing an overall grade of B+ (7.1/10). Well-supported for skin, hair, wound healing.

What safety findings are reported for Red light therapy / photobiomodulation (PBM)?

Red light therapy / photobiomodulation (PBM) has a low risk profile in the database. Low Legal status: OTC (devices).

What doses or routes are reported for Red light therapy / photobiomodulation (PBM)?

Red (630-660 nm) and NIR (810-850 nm); 3-20 min per area; daily or 3-5x/week This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.

Rankings / Mitochondria & Cellular Energy

Red light therapy / photobiomodulation (PBM)

Mitochondria & Cellular Energy · Light

Tier B+

Reviewed by Read Off Label · Last reviewed Aug 6, 2026 · How we grade

photobiomodulationanti-inflammatoryotc

7.1 / 10

Tier B+

Ev 6 Bn 5 Sf 9

Bottom line

Read Off Label grades Red light therapy / photobiomodulation (PBM) as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.

Well-supported for skin, hair, wound healing.

Studied, labeled, or reported-use context: Red (630-660 nm) and NIR (810-850 nm); 3-20 min per area; daily or 3-5x/week — OTC; not individualized guidance.

What the evidence says

Well-supported for skin, hair, wound healing. Expanding body of evidence for MSK pain and tendon healing. Thyroid/Hashimoto's signal in Brazilian studies. Device quality varies widely. A 2026 Bayesian network meta-analysis (34 studies, 35 RCTs, n=1,559) in Alzheimer's disease found PBM outperformed tDCS and rTMS on cognitive outcomes (MMSE +3.14, ADAS-Cog -8.01 vs control); this is real RCT-level evidence, but specific to a dementia population under clinical protocols, not a general cognitive-enhancement claim for healthy adults.

Mechanism

Red/near-infrared light (600-1100 nm) absorbed by cytochrome c oxidase — increases ATP production; modulates ROS; anti-inflammatory

Studied, labeled, or reported dose & route

Red (630-660 nm) and NIR (810-850 nm); 3-20 min per area; daily or 3-5x/week

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Red light therapy / photobiomodulation (PBM)'s effects?: Read Off Label rates the evidence for Red light therapy / photobiomodulation (PBM) as Moderate and the benefit magnitude as med, producing an overall grade of B+ (7.1/10). Well-supported for skin, hair, wound healing.
What safety findings are reported for Red light therapy / photobiomodulation (PBM)?: Red light therapy / photobiomodulation (PBM) has a low risk profile in the database. Low Legal status: OTC (devices).
What doses or routes are reported for Red light therapy / photobiomodulation (PBM)?: Red (630-660 nm) and NIR (810-850 nm); 3-20 min per area; daily or 3-5x/week This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Red light therapy / photobiomodulation (PBM) work?: Red/near-infrared light (600-1100 nm) absorbed by cytochrome c oxidase — increases ATP production; modulates ROS; anti-inflammatory

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.